Search company, investor...
Cell Line Genetics company logo

Cell Line Genetics

clgenetics.com

Stage

Debt | Alive

Total Raised

$250K

Last Raised

$250K | 14 yrs ago

About Cell Line Genetics

Cell Line Genetics aims to provide services and products to support research institutions, as well as biotechnology and pharmaceutical companies focused on embryonic stem cell and cancer research.

Headquarters Location

510 Charmany Drive Ste 254

Madison, Wisconsin, 53719,

United States

608-441-8160

Missing: Cell Line Genetics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cell Line Genetics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Cell Line Genetics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cell Line Genetics is included in 3 Expert Collections, including Cancer.

C

Cancer

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Cell Line Genetics News

Worldwide Cell Line Authentication and Characterization Tests Industry to 2031 - Featuring Cell Line Genetics, GenomeScan and Promega Among Others - ResearchAndMarkets.com

Jan 14, 2022

This report on the global cell line authentication and characterization tests market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global cell line authentication and characterization tests market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cell line authentication and characterization tests market for the forecast period. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cell line authentication and characterization tests market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global cell line authentication and characterization tests market. The next section of the global cell line authentication and characterization tests market report highlights the USPs such as standards for cell authentication and characteristics, list of cell line providers, key industry events (mergers, acquisitions, partnerships, etc. ), key product/brand analysis, and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact), and key success factors of top players operating in the global cell line authentication and characterization tests market. The report also delves into the competition landscape of the global cell line authentication and characterization tests market. Key players operating in the global cell line authentication and characterization tests market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, strategic overview, and SWOT are some of the attributes of players in the global cell line authentication and characterization tests market profiled in this report. Companies Mentioned Microsynth AG Thermo Fisher Scientific, Inc. 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.2. List of Cell Line Providers 5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.) 5.4. Key Product/Brand Analysis 6. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Test Type 7. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Application 8. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by End-user 9. Global Cell Line Authentication and Characterization Tests Market Analysis and Forecast, by Region 10. North America Cell Line Authentication and Characterization Tests Market Analysis and Forecast 11. Europe Cell Line Authentication and Characterization Tests Market Analysis and Forecast 12. Asia Cell Line Authentication and Characterization Tests Market Analysis and Forecast 13. Latin America Cell Line Authentication and Characterization Tests Market Analysis and Forecast 14. Middle East & Africa Cell Line Authentication and Characterization Tests Market Analysis and Forecast 15. Competition Landscape 15.2. Market Share Analysis By Company (2020) 15.3. Company Profiles Contacts

Cell Line Genetics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cell Line Genetics Rank

Cell Line Genetics Frequently Asked Questions (FAQ)

  • Where is Cell Line Genetics's headquarters?

    Cell Line Genetics's headquarters is located at 510 Charmany Drive, Madison.

  • What is Cell Line Genetics's latest funding round?

    Cell Line Genetics's latest funding round is Debt.

  • How much did Cell Line Genetics raise?

    Cell Line Genetics raised a total of $250K.

  • Who are the investors of Cell Line Genetics?

    Investors of Cell Line Genetics include Wisconsin Technology Venture Fund and MGE Innovation Center.

  • Who are Cell Line Genetics's competitors?

    Competitors of Cell Line Genetics include Minerva Biotechnologies, Oceanit, Animal Cell Therapies, Noveome Biotherapeutics, Seattle Genetics, Akron Biotechnology, NGM Biopharmaceuticals, ReInnervate, Alta Devices, ReSearch Pharmaceutical Services and 14 more.

Compare Cell Line Genetics to Competitors

A
American Stem Cell

ASC is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potential of stem cell therapies. The key technology platforms (ASC-101 and ASC-201) are designed to improve the homing and engraftment of stem cells to target organs and increase their therapeutic potential for cancer patients. Additionally, these platforms have the potential to enhance stem cell treatment of inflammation from chemotherapy/radiation, solid tumors, autoimmune diseases, and ischemic diseases including myocardial infarction and stroke. ASC has strategic partnerships with medical research institutions including the University of Texas M.D. Anderson Cancer Center, the Oklahoma Medical Research Foundation, University of California, the Burnham Institute, Indiana University, Rush Presbyterian and VidaCord Technologia Biomedica.

Minerva Biotechnologies Logo
Minerva Biotechnologies

Minerva Biotechnologies developd biochips: nanoparticles coated with functionalized affinity surfaces. Minerva has developed user-friendly nanoparticles that the end user can utilize as a "black box technology". The nanoparticle system can be fully automated and a range of nanoparticles have been developed so that the readout is compatible with existing lab equipment.

A
Animal Cell Therapies

Animal Cell Therapies is a biotech firm that aims to improve the lives of animals through thoughtful research and development. The ACT team is focused on developing and delivering cellular treatment and services to customers.

Noveome Biotherapeutics Logo
Noveome Biotherapeutics

Noveome Biotherapeutics is regenerative medicine company focused on the research, development and clinical use of its technology platform, derived from human placental cells. This platform provides a new approach to tissue regeneration and repair in a wide range of medical conditions. Noveome's technology platform is derived from a population of cells isolated from full-term placental tissue that is normally discarded following delivery of a baby. There is no interruption in the development of the baby to procure this tissue.

A
Akron Biotechnology

Akron Biotechnology provides its customers with quality raw materials and components for research and development. As a scientific product supplier, the company specializes in manufacturing and supplying chemicals, biochemicals, cell culture, and cell biology products aimed at the biopharmaceutical and biotechnology markets.

G
Global Cell Solutions

Global Cell Solutions, headquartered in Charlottesville, Virginia, is focused on the application of a improved patent-pending cell culturing technique. Global Cell is positioned to be an integral partner to scientific s in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.